AVTR - Avantor, Inc.
NYSE
->
Basic Materials
->
Specialty Chemicals
Radnor,
United States
Type: Equity
AVTR price evolution
AVTR
| (in millions $) | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $234.9 | $262.9 | $236.9 | $236.4 |
| Short term investments | ||||
| Net receivables | $1129.7 | $1150.2 | $1150.3 | $1216 |
| Inventory | $810.6 | $828.1 | $850.3 | $890.4 |
| Total current assets | $2321.1 | $2384.9 | $2384.8 | $2499.1 |
| Long term investments | ||||
| Property, plant & equipment | $739.7 | $737.5 | $698.3 | $698.2 |
| Goodwill & intangible assets | $9334.9 | $9492 | $9425.8 | $9589.3 |
| Total noncurrent assets | $10442.3 | $10587.8 | $10413.3 | $10564.2 |
| Total investments | ||||
| Total assets | $12763.4 | $12972.7 | $12798.1 | $13063.3 |
| Current liabilities | ||||
| Accounts payable | $573.4 | $625.9 | $655.8 | $686.6 |
| Deferred revenue | ||||
| Short long term debt | $299.1 | $259.9 | $335.6 | $314 |
| Total current liabilities | $1441.9 | $1480.3 | $1488.1 | $1550.1 |
| Long term debt | $5023.9 | $5276.7 | $5290.5 | $5570.3 |
| Total noncurrent liabilities | $5985.2 | $6239.8 | $6210.6 | $6501.9 |
| Total debt | $5323 | $5536.6 | $5626.1 | $5884.3 |
| Total liabilities | $7427.1 | $7720.1 | $7698.7 | $8052 |
| Shareholders' equity | ||||
| Retained earnings | $1551.9 | $1491.5 | $1393 | $1284.6 |
| Other shareholder equity | -$97 | -$69 | -$111.1 | -$71.9 |
| Total shareholder equity | $5336.3 | $5252.6 | $5099.4 | $5011.3 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $262.9 | $372.9 | $301.7 | $286.6 |
| Short term investments | ||||
| Net receivables | $1150.2 | $1218.4 | $1222.1 | $1113.3 |
| Inventory | $828.1 | $913.5 | $872 | $739.6 |
| Total current assets | $2384.9 | $2657.9 | $2477.2 | $2230.9 |
| Long term investments | ||||
| Property, plant & equipment | $737.5 | $845.7 | $705.5 | $549.9 |
| Goodwill & intangible assets | $9492 | $9785.9 | $10481.4 | $6909 |
| Total noncurrent assets | $10587.8 | $10806.4 | $11420 | $7675.6 |
| Total investments | ||||
| Total assets | $12972.7 | $13464.3 | $13897.2 | $9906.5 |
| Current liabilities | ||||
| Accounts payable | $625.9 | $758.2 | $755.1 | $678.9 |
| Deferred revenue | ||||
| Short long term debt | $259.9 | $364.2 | $45.2 | $26.4 |
| Total current liabilities | $1480.3 | $1658.8 | $1450.8 | $1242.7 |
| Long term debt | $5276.7 | $5923.3 | $6978 | $4867.5 |
| Total noncurrent liabilities | $6239.8 | $6950.1 | $8249.4 | $5989.5 |
| Total debt | $5536.6 | $6287.5 | $7023.2 | $4893.9 |
| Total liabilities | $7720.1 | $8608.9 | $9700.2 | $7232.2 |
| Shareholders' equity | ||||
| Retained earnings | $1491.5 | $1170.4 | $483.9 | -$88.7 |
| Other shareholder equity | -$69 | -$100.3 | -$43.2 | $21.7 |
| Total shareholder equity | $5252.6 | $4855.4 | $4197 | $2674.3 |
| (in millions $) | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1679.8 | $1722.8 | $1720.2 | $1743.9 |
| Cost of revenue | $1109.3 | $1152.4 | $1141.6 | $1153.9 |
| Gross Profit | $570.5 | $570.4 | $578.6 | $590 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $424.2 | $387.1 | $368.4 | $357.5 |
| Total operating expenses | $424.2 | $387.1 | $368.4 | $518.3 |
| Operating income | $146.3 | $183.3 | $210.2 | $71.7 |
| Income from continuing operations | ||||
| EBIT | $144.9 | $184.8 | $208.9 | $72.1 |
| Income tax expense | $20.2 | $21 | $28.1 | $6 |
| Interest expense | $64.3 | $65.3 | $72.4 | $73.4 |
| Net income | ||||
| Net income | $60.4 | $98.5 | $108.4 | -$7.3 |
| Income (for common shares) | $60.4 | $98.5 | $108.4 | -$7.3 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $6967.2 | $7512.4 | $7386.1 | $6393.6 |
| Cost of revenue | $4603.4 | $4909.6 | $4883.4 | $4313.1 |
| Gross Profit | $2363.8 | $2602.8 | $2502.7 | $2080.5 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $1506.6 | $1472.6 | $1530.5 | $1373.7 |
| Total operating expenses | $1667.4 | $1472.6 | $1530.5 | $1373.7 |
| Operating income | $696.4 | $1130.2 | $972.2 | $706.8 |
| Income from continuing operations | ||||
| EBIT | $695.3 | $1116.9 | $970.4 | $369.9 |
| Income tax expense | $89.4 | $164.6 | $180.4 | -$54.3 |
| Interest expense | $284.8 | $265.8 | $217.4 | $307.6 |
| Net income | ||||
| Net income | $321.1 | $686.5 | $572.6 | $116.6 |
| Income (for common shares) | $321.1 | $662.3 | $508 | $52 |
| (in millions $) | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 |
|---|---|---|---|---|
| Net income | $60.4 | $98.5 | $108.4 | -$7.3 |
| Operating activities | ||||
| Depreciation | $99.6 | $100.6 | $98 | $102.6 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $12.7 | $8.8 | $9.8 | $9.2 |
| Total cash flows from operations | $141.6 | $251.6 | $230.7 | $168.2 |
| Investing activities | ||||
| Capital expenditures | -$34.7 | -$50.6 | -$37.7 | -$30.1 |
| Investments | ||||
| Total cash flows from investing | -$34.2 | -$50 | -$37 | -$29.4 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $38.9 | $4 | $9.2 | -$3.1 |
| Net borrowings | -$169.1 | -$188.1 | -$197.6 | -$193.1 |
| Total cash flows from financing | -$130.2 | -$184.1 | -$188.4 | -$196.2 |
| Effect of exchange rate | -$5.7 | $9.5 | -$5.4 | -$0.7 |
| Change in cash and equivalents | -$28.5 | $27 | -$0.1 | -$58.1 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $321.1 | $686.5 | $572.6 | $116.6 |
| Operating activities | ||||
| Depreciation | $402.3 | $405.5 | $379.2 | $395.4 |
| Business acquisitions & disposals | -$20.2 | -$4014.1 | ||
| Stock-based compensation | $40.5 | $45.8 | $50.7 | $44.1 |
| Total cash flows from operations | $870 | $843.6 | $953.6 | $929.8 |
| Investing activities | ||||
| Capital expenditures | -$146.4 | -$133.4 | -$111.1 | -$61.6 |
| Investments | ||||
| Total cash flows from investing | -$143.7 | -$109.6 | -$4121.7 | -$59.1 |
| Financing activities | ||||
| Dividends paid | -$64.6 | |||
| Sale and purchase of stock | $4.6 | $4.1 | $1023.7 | $20.2 |
| Net borrowings | -$848.3 | -$620.4 | $2260.1 | -$738.5 |
| Total cash flows from financing | -$843.7 | -$648.7 | $3219.2 | -$782.9 |
| Effect of exchange rate | $8.2 | -$15.5 | -$13.2 | $12.1 |
| Change in cash and equivalents | -$109.2 | $69.8 | $37.9 | $99.9 |
News
|
Earnings call: Avantor maintains guidance despite Q1 revenue dip
Investing.com
29 Apr 2024
|
|
Avantor (AVTR) Q1 Earnings Surpass Estimates, Margins Down
Zacks
29 Apr 2024
|
|
Decoding Avantor Inc (AVTR): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance
27 Apr 2024
|
|
The Zacks Analyst Blog Highlights Cigna Group, HCA Healthcare, Avantor and Tenet Healthcare
Zacks via Yahoo Finance
26 Apr 2024
|
|
ELV or AVTR: Which Is the Better Value Stock Right Now?
Zacks via Yahoo Finance
26 Apr 2024
|
|
Avantor shares edge up on earnings beat By Investing.com
Investing.com
26 Apr 2024
|
|
Is a Surprise Coming for Avantor (AVTR) This Earnings Season?
Zacks via Yahoo Finance
26 Apr 2024
|
|
Is There An Opportunity With Avantor, Inc.'s (NYSE:AVTR) 39% Undervaluation?
Simply Wall St. via Yahoo Finance
13 Apr 2024
|
|
Three Reasons to Retain Avantor (AVTR) Stock in Your Portfolio
Zacks via Yahoo Finance
26 Mar 2024
|
|
Top 12 Stocks in George Soros’ Stock Portfolio
Insider Monkey via Yahoo Finance
24 Mar 2024
|
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | $6.87B |
|---|---|
| EBITDA | $1.01B |
| EBIT | $610.70M |
| Net Income | $260.00M |
| Revenue Q/Q | -5.65% |
| Revenue Y/Y | -6.48% |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | 2.02% |
| ROE | 5.02% |
| Debt/Equity | 1.47 |
|---|---|
| Net debt/EBITDA | 7.11 |
| Current ratio | 1.61 |
| Quick ratio | 1.05 |